<<<You have to be kidding, right? Copaxone has to be among the most sophisticated drugs I know of, both in terms of its composition and its mode of action.>>>
But Teva did not develop it, and Teva has not developed any significant drugs in over 15 years since copaxone obtained U.S. approval:
That is simply not Teva's business, to develop complex, sophisticated drugs. That is not a slight against Teva, it is just not their business and their core competencies.
Teva admits that themselves from their won web-site: Proven Success - We're building on our successes in developing proprietary therapies such as the blockbuster COPAXONE® and AZILECT® - the rights to both of which were acquired from renowned institutions.
Now that Teva has tons of cash to burn, they are trying to morph into a more standard R&D sort of company, mostly by acquiring such targets I would imagine. But since 1996, I am not aware of any branded Teva innovator drug?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.